Eagle Pharmaceuticals IncNASDAQ:EGRX
- LAST PRICE35.7900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots34.0000/ 1
- Ask / Lots49.0800/ 1
- Open / Previous Close34.6500 / 35.7900
- Day Range
- 52 Week Range
- Volume265,392
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EGRX |
|---|---|---|
| 09:32 ET | 1261 | 34.22 |
| 09:36 ET | 200 | 34.72 |
| 09:39 ET | 100 | 34.815 |
| 09:41 ET | 300 | 35.015 |
| 09:45 ET | 200 | 35.16 |
| 09:50 ET | 100 | 35.085 |
| 09:52 ET | 800 | 35.06 |
| 09:54 ET | 100 | 35.17 |
| 09:56 ET | 600 | 35.17 |
| 09:59 ET | 895 | 35.08 |
| 10:01 ET | 900 | 35.11 |
| 10:06 ET | 490 | 34.91 |
| 10:08 ET | 100 | 34.99 |
| 10:10 ET | 300 | 35.13 |
| 10:12 ET | 200 | 35.14 |
| 10:14 ET | 400 | 35.15 |
| 10:15 ET | 367 | 35.395 |
| 10:17 ET | 100 | 35.35 |
| 10:19 ET | 100 | 35.37 |
| 10:21 ET | 1895 | 35.27 |
| 10:24 ET | 600 | 35.21 |
| 10:28 ET | 100 | 35.15 |
| 10:30 ET | 100 | 35.26 |
| 10:32 ET | 755 | 35.22 |
| 10:33 ET | 1141 | 35.23 |
| 10:37 ET | 238 | 35.185 |
| 10:39 ET | 790 | 35.24 |
| 10:42 ET | 2495 | 35.23 |
| 10:44 ET | 500 | 35.27 |
| 10:48 ET | 300 | 35.21 |
| 10:50 ET | 200 | 35.33 |
| 10:53 ET | 100 | 35.455 |
| 10:55 ET | 400 | 35.47 |
| 10:57 ET | 900 | 35.38 |
| 11:02 ET | 100 | 35.39 |
| 11:04 ET | 400 | 35.43 |
| 11:06 ET | 600 | 35.6 |
| 11:08 ET | 813 | 35.74 |
| 11:09 ET | 200 | 35.81 |
| 11:11 ET | 1651 | 35.76 |
| 11:13 ET | 200 | 35.83 |
| 11:15 ET | 600 | 35.83 |
| 11:18 ET | 100 | 35.88 |
| 11:20 ET | 553 | 35.94 |
| 11:22 ET | 100 | 36.13 |
| 11:24 ET | 100 | 35.96 |
| 11:27 ET | 1510 | 35.82 |
| 11:29 ET | 400 | 35.85 |
| 11:33 ET | 100 | 35.88 |
| 11:38 ET | 100 | 35.71 |
| 11:40 ET | 300 | 35.625 |
| 11:42 ET | 100 | 35.77 |
| 11:45 ET | 100 | 35.665 |
| 11:47 ET | 100 | 35.75 |
| 11:49 ET | 400 | 35.56 |
| 11:51 ET | 100 | 35.745 |
| 11:54 ET | 400 | 35.56 |
| 11:56 ET | 100 | 35.57 |
| 11:58 ET | 400 | 35.51 |
| 12:02 ET | 100 | 35.555 |
| 12:03 ET | 500 | 35.43 |
| 12:05 ET | 400 | 35.5 |
| 12:07 ET | 200 | 35.62 |
| 12:09 ET | 100 | 35.725 |
| 12:12 ET | 100 | 35.62 |
| 12:14 ET | 1200 | 35.59 |
| 12:16 ET | 2200 | 35.59 |
| 12:20 ET | 235 | 35.64 |
| 12:21 ET | 100 | 35.755 |
| 12:23 ET | 417 | 35.64 |
| 12:27 ET | 1300 | 35.58 |
| 12:30 ET | 100 | 35.66 |
| 12:32 ET | 300 | 35.66 |
| 12:36 ET | 100 | 35.735 |
| 12:38 ET | 900 | 35.735 |
| 12:41 ET | 200 | 35.715 |
| 12:43 ET | 100 | 35.596 |
| 12:45 ET | 362 | 35.73 |
| 12:52 ET | 100 | 35.7 |
| 12:54 ET | 500 | 35.75 |
| 12:57 ET | 300 | 35.8 |
| 12:59 ET | 218 | 35.72 |
| 01:03 ET | 100 | 35.9 |
| 01:06 ET | 100 | 35.74 |
| 01:08 ET | 200 | 35.77 |
| 01:12 ET | 100 | 35.78 |
| 01:14 ET | 100 | 35.77 |
| 01:15 ET | 800 | 35.82 |
| 01:17 ET | 2601 | 35.45 |
| 01:24 ET | 100 | 35.54 |
| 01:26 ET | 100 | 35.61 |
| 01:30 ET | 100 | 35.63 |
| 01:33 ET | 600 | 35.52 |
| 01:37 ET | 1108 | 35.665 |
| 01:39 ET | 100 | 35.74 |
| 01:42 ET | 100 | 35.78 |
| 01:44 ET | 200 | 35.9 |
| 01:48 ET | 368 | 35.775 |
| 01:51 ET | 100 | 35.765 |
| 01:55 ET | 977 | 35.785 |
| 01:57 ET | 100 | 35.82 |
| 02:00 ET | 1519 | 35.76 |
| 02:02 ET | 250 | 35.87 |
| 02:04 ET | 600 | 35.92 |
| 02:06 ET | 1388 | 35.84 |
| 02:09 ET | 1090 | 35.79 |
| 02:11 ET | 300 | 35.84 |
| 02:20 ET | 619 | 35.8325 |
| 02:22 ET | 100 | 35.915 |
| 02:24 ET | 200 | 35.86 |
| 02:26 ET | 190 | 35.9053 |
| 02:27 ET | 100 | 35.925 |
| 02:29 ET | 558 | 35.925 |
| 02:31 ET | 8556 | 36.175 |
| 02:36 ET | 539 | 36.175 |
| 02:38 ET | 815 | 36.15 |
| 02:40 ET | 100 | 36.17 |
| 02:42 ET | 100 | 36.305 |
| 02:44 ET | 1260 | 36.23 |
| 02:45 ET | 700 | 36.26 |
| 02:47 ET | 100 | 36.25 |
| 02:49 ET | 200 | 36.25 |
| 02:51 ET | 100 | 36.315 |
| 02:54 ET | 100 | 36.265 |
| 02:56 ET | 1400 | 36.21 |
| 02:58 ET | 700 | 35.96 |
| 03:00 ET | 100 | 36.03 |
| 03:02 ET | 200 | 35.97 |
| 03:03 ET | 2620 | 36.22 |
| 03:05 ET | 8934 | 36.44 |
| 03:07 ET | 100 | 36.41 |
| 03:09 ET | 300 | 36.38 |
| 03:12 ET | 516 | 36.31 |
| 03:14 ET | 3697 | 36.13 |
| 03:16 ET | 100 | 36.13 |
| 03:18 ET | 11551 | 35.75 |
| 03:20 ET | 200 | 35.65 |
| 03:21 ET | 1656 | 35.75 |
| 03:23 ET | 2972 | 35.75 |
| 03:25 ET | 1200 | 35.75 |
| 03:27 ET | 1667 | 35.68 |
| 03:30 ET | 500 | 35.75 |
| 03:32 ET | 300 | 35.8 |
| 03:34 ET | 100 | 35.8 |
| 03:36 ET | 1200 | 35.73 |
| 03:39 ET | 1500 | 35.9 |
| 03:41 ET | 5525 | 35.84 |
| 03:43 ET | 700 | 35.83 |
| 03:45 ET | 700 | 35.69 |
| 03:48 ET | 800 | 35.89 |
| 03:50 ET | 300 | 35.85 |
| 03:52 ET | 400 | 35.79 |
| 03:54 ET | 700 | 35.925 |
| 03:56 ET | 14442 | 35.49 |
| 03:57 ET | 23252 | 35.17 |
| 03:59 ET | 34056 | 35.79 |
Aug 9, 2022
BRIEF-Eagle Pharmaceuticals Takes Equity Stake In, With Option To Acquire, Enalare Therapeutics , from 8:07AM ET on Tuesday Aug 09, 2022 by Thomson Reuters
8:07AM ET on Tuesday Aug 09, 2022 by Thomson ReutersEagle Pharmaceuticals Agrees to Invest Up to $55 Million in Enalare Therapeutics, from 8:05AM ET on Tuesday Aug 09, 2022 by MT Newswires
8:05AM ET on Tuesday Aug 09, 2022 by MT NewswiresEagle Pharmaceuticals Reports Higher Q2 Adjusted Earnings, Revenue, from 7:16AM ET on Tuesday Aug 09, 2022 by MT Newswires
7:16AM ET on Tuesday Aug 09, 2022 by MT NewswiresBRIEF-Eagle Pharmaceuticals reports Q2 results, from 6:54AM ET on Tuesday Aug 09, 2022 by Thomson Reuters
6:54AM ET on Tuesday Aug 09, 2022 by Thomson Reuters-- Earnings Flash (EGRX) EAGLE PHARMACEUTICALS Reports Q2 Revenue $74.1M, from 6:51AM ET on Tuesday Aug 09, 2022 by MT Newswires
6:51AM ET on Tuesday Aug 09, 2022 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Eagle Pharmaceuticals Inc | 444.4M | 12.9x | --- |
Shengtai Pharmaceutical Inc | 239.6K | 0.0x | --- |
Dbv Technologies SA | 493.0M | -3.9x | --- |
Medicine Man Technologies Inc | 52.2M | -2.3x | --- |
TherapeuticsMD Inc | 81.1M | -0.4x | --- |
Lotus Pharmaceuticals Inc | 33.1M | 0.2x | +42.39% |
Company Information
Eagle Pharmaceuticals, Inc. is a pharmaceutical company. The Company's products include Ryanodex, Bendeka, Belrapzo, Treakisym, Pemfexy, Barhemsys and Byfavo. Ryanodex is used for malignant hyperthermia. EP-4104 Ryanodex (dantrolene sodium) is used for the treatment of organophosphate exposure. Belrapzo, Bendeka and Treakisym are used for chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Pemfexy is an IV-administered cancer agent indicated for locally advanced or metastatic non-small cell lung cancer and mesothelioma. Its oncology and CNS/metabolic critical care pipeline includes product candidates that addresses underserved therapeutic areas across multiple disease states. Its vasopressin is an A-rated generic alternative to Vasostrict, which is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. It is engaged in clinical trials for CAL02, an approach to the treatment of severe bacterial pneumonia.
Contact Information
- Headquarters
- 50 Tice Boulevard, Suite 315WOODCLIFF LAKE, NJ, United States 07677
- Phone
- 201-326-5300
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Michael Graves
- President, Chief Executive Officer, Director
- Scott Tarriff
- Chief Financial Officer
- Brian Cahill
- Independent Director
- Luciana Borio
- Independent Director
- Richard Edlin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $444.4M |
|---|---|
Revenue (TTM) | $246.2M |
Shares Outstanding | 12.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.62 |
EPS | $2.78 |
Book Value | $13.79 |
P/E Ratio | 12.9x |
Price/Sales (TTM) | 1.8 |
Price/Cash Flow (TTM) | 11.2x |
Operating Margin | 26.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
